Chugai Pharmaceutical Co.... (CHGCF)
Company Description
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; osteoporosis, including Actemra, Edirol, and Bonviva; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng.
It has various development product candidates in the areas of oncology, immunology, neuroscience, hematology, ophthalmology, and other diseases.
Chugai Pharmaceutical Co., Ltd. has strategic alliances with Roche Group; and collaboration and joint research with academia.
The company was founded in 1925 and is headquartered in Chuo, Japan.
Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd.
| Country | JP |
| IPO Date | Aug 3, 2012 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 5,026 |
| CEO | Dr. Osamu Okuda |
Contact Details
Address: 2-1-1 Nihonbashi-Muromachi Chuo, JP | |
| Website | https://www.chugai-pharm.co.jp |
Stock Details
| Ticker Symbol | CHGCF |
| Exchange | PNK |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | JP3519400000 |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Dr. Osamu Okuda | President, Chief Executive Officer & Chairman |
| Iwaaki Taniguchi | Executive Vice President, Head of Finance Supervisory Division, Chief Financial Officer & Director |
| Dr. Kaori Ouchi | Executive Vice President |
| Dr. Tomoyuki Igawa Ph.D. | Vice President & Head of Research Division |
| Junichi Takano | Head of Marketing & Sales Division |
| Kosuke Iijima | Head of PHC Solution Department |
| Shinji Hidaka | Executive Vice President |
| Tetsuya Yamaguchi | Executive Vice President |
| Toshiya Sasai | Executive of Investor Relations Group & Corporate Communications Department |
| Yoshiyuki Yano | Executive Vice President |